Annual Interest Expense
$18.95 M
+$4.04 M+27.09%
31 December 2023
Summary:
CymaBay Therapeutics annual interest expense is currently $18.95 million, with the most recent change of +$4.04 million (+27.09%) on 31 December 2023. During the last 3 years, it has risen by +$16.36 million (+633.45%).CBAY Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$5.08 M
+$238.00 K+4.91%
31 December 2023
Summary:
CymaBay Therapeutics quarterly interest expense is currently $5.08 million, with the most recent change of +$238.00 thousand (+4.91%) on 31 December 2023.CBAY Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$18.95 M
+$1.01 M+5.61%
31 December 2023
Summary:
CymaBay Therapeutics TTM interest expense is currently $18.95 million, with the most recent change of +$1.01 million (+5.61%) on 31 December 2023.CBAY TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +633.5% | +146.5% | +633.5% |
| 5 y5 years | - | - | - |
CBAY Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | at high | at high |
CymaBay Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $18.95 M(+27.1%) | $5.08 M(+4.9%) | $18.95 M(+5.6%) |
| Sept 2023 | - | $4.84 M(+4.9%) | $17.94 M(+6.1%) |
| June 2023 | - | $4.62 M(+4.9%) | $16.91 M(+6.1%) |
| Mar 2023 | - | $4.40 M(+8.0%) | $15.95 M(+7.0%) |
| Dec 2022 | $14.91 M(+477.1%) | $4.08 M(+6.7%) | $14.91 M(+15.6%) |
| Sept 2022 | - | $3.82 M(+4.7%) | $12.89 M(+34.4%) |
| June 2022 | - | $3.65 M(+8.4%) | $9.60 M(+61.3%) |
| Mar 2022 | - | $3.37 M(+63.3%) | $5.95 M(+130.3%) |
| Dec 2021 | $2.58 M(>+9900.0%) | $2.06 M(+294.8%) | $2.58 M(+394.8%) |
| Sept 2021 | - | $522.00 K(>+9900.0%) | $522.00 K(>+9900.0%) |
| June 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2018 | $336.00 K(-68.9%) | $0.00(0.0%) | $336.00 K(-41.1%) |
| Sept 2018 | - | $0.00(-100.0%) | $570.00 K(-31.2%) |
| June 2018 | - | $128.00 K(-38.5%) | $828.00 K(-15.8%) |
| Mar 2018 | - | $208.00 K(-11.1%) | $983.00 K(-9.0%) |
| Dec 2017 | $1.08 M | $234.00 K(-9.3%) | $1.08 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $258.00 K(-8.8%) | $1.17 M(-6.6%) |
| June 2017 | - | $283.00 K(-7.2%) | $1.26 M(-4.0%) |
| Mar 2017 | - | $305.00 K(-7.0%) | $1.31 M(-2.0%) |
| Dec 2016 | $1.34 M(+46.4%) | $328.00 K(-3.8%) | $1.34 M(-0.1%) |
| Sept 2016 | - | $341.00 K(+1.5%) | $1.34 M(+6.0%) |
| June 2016 | - | $336.00 K(+1.2%) | $1.26 M(+15.7%) |
| Mar 2016 | - | $332.00 K(+0.9%) | $1.09 M(+19.5%) |
| Dec 2015 | $913.00 K(+20.9%) | $329.00 K(+24.2%) | $913.00 K(+18.0%) |
| Sept 2015 | - | $265.00 K(+60.6%) | $774.00 K(+10.6%) |
| June 2015 | - | $165.00 K(+7.1%) | $700.00 K(-3.3%) |
| Mar 2015 | - | $154.00 K(-18.9%) | $724.00 K(-4.0%) |
| Dec 2014 | $755.00 K(-8.2%) | $190.00 K(-0.5%) | $754.00 K(+1.1%) |
| Sept 2014 | - | $191.00 K(+1.1%) | $746.00 K(-3.6%) |
| June 2014 | - | $189.00 K(+2.7%) | $774.00 K(-2.5%) |
| Mar 2014 | - | $184.00 K(+1.1%) | $794.00 K(-3.4%) |
| Dec 2013 | $822.00 K(-2.3%) | $182.00 K(-16.9%) | $822.00 K(+28.4%) |
| Sept 2013 | - | $219.00 K(+4.8%) | $640.00 K(+52.0%) |
| June 2013 | - | $209.00 K(-1.4%) | $421.00 K(+98.6%) |
| Mar 2013 | - | $212.00 K | $212.00 K |
| Dec 2012 | $841.00 K | - | - |
FAQ
- What is CymaBay Therapeutics annual interest expense?
- What is the all time high annual interest expense for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for CymaBay Therapeutics?
- What is CymaBay Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for CymaBay Therapeutics?
What is CymaBay Therapeutics annual interest expense?
The current annual interest expense of CBAY is $18.95 M
What is the all time high annual interest expense for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual interest expense is $18.95 M
What is CymaBay Therapeutics quarterly interest expense?
The current quarterly interest expense of CBAY is $5.08 M
What is the all time high quarterly interest expense for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly interest expense is $5.08 M
What is CymaBay Therapeutics TTM interest expense?
The current TTM interest expense of CBAY is $18.95 M
What is the all time high TTM interest expense for CymaBay Therapeutics?
CymaBay Therapeutics all-time high TTM interest expense is $18.95 M